Directed issue of shares in Active Biotech (SE) — SEK 340 million Healthcare Directed issue of shares in Active Biotech (SE) — SEK 340 million
Secondary placing of shares in Capio AB (SE) — SEK 313 million Healthcare Secondary placing of shares in Capio AB (SE) — SEK 313 million
Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million Healthcare Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million
Initial public offering of Orexo (SE) — SEK 333 million Healthcare Initial public offering of Orexo (SE) — SEK 333 million
Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million Healthcare Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million
New share issue in Fastighets AB Klövern (SE) — SEK 260 million Real Estate New share issue in Fastighets AB Klövern (SE) — SEK 260 million
Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million FIG Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million
Rights issue in Active Biotech (SE) — SEK 255 million Healthcare Rights issue in Active Biotech (SE) — SEK 255 million
Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion Healthcare Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion
Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion Healthcare Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion
Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million Healthcare Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million